Percy Leung Reiterates Buy on Sunlight REIT, Trims Target Price to HKD2.66 While Highlighting Attractive 7.5%+ Yield and Hong Kong Leasing Recovery Upside
DBS Remains a Buy on Sunlight Real Estate Investment (SHTRF)
Henderson Land Renews Sunlight REIT Service Deals and Sets New Caps to 2029
Sunlight Launches Sunlight NAD+ Rx, a Clinician-Supervised NAD+ Program Delivered Through Its Clinical Pathway
Reviewed by Dr. Angela Tran, MD, board-certified in internal and obesity medicine, Chief Medical Advisor at Sunlight.KIRKLAND, Wash., May 26, 2026 /PRNewswire/ -- Sunlight NAD+ Rx, the company's
SUNLIGHT HLDGS: 2026 INTERIM REPORT
SUNLIGHT HLDGS: ANNOUNCEMENT OF THE INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2026
Zhitong HK Stock Investment Diary | May 15
Hong Kong Stock Investment Diary | May 15, 2026
SUNLIGHT HLDGS: DATE OF BOARD MEETING